| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.02 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |